Key Takeaways
- Volume doubled, mix shifted: Q3 volumes rose 100% YoY, but revenue growth lagged because the fast-growing FMCG cleaning & hygiene segment carries lower per-kilo realizations than textile specialties.
- Margins held despite new-plant drag: EBITDA margin reached 26.1% in Q3 even as a newly commissioned 21,000-ton plant added pre-operative costs before producing a single kilo, a result management credits to automation and larger reactor sizes.
- The FMCG pivot is real and accelerating: Cleaning & hygiene has grown nearly 20x in five quarters, big brands like Patanjali are now onboard, and a large ₹150-crore FMCG order began shipping in December with the bulk pushed into Q4.
- Textile demand is turning, not broken: No customers or products were lost during the soft patch; from mid-January, order inflow improved materially, and management urges investors to view textiles on a two-year average, not quarter by quarter.
- What to watch next quarter: Whether Q4 volumes hit the targeted 18,000–20,000 tons, how much of the postponed FMCG order actually ships, and whether the textile recovery sustains beyond the initial restocking pulse.
The FMCG Pivot: From Textile Specialist to Cleaning & Hygiene Platform
- Scale of the shift: Cleaning, hygiene and FMCG business has grown almost 20x in the last five quarters, and management expects it to contribute 40–50% of overall turnover going forward.
- Why it matters for quality: FMCG demand is less wavy than textiles, where cotton-price swings cause production stops and starts; the business is described as "COVID-proof" and carries better cash-flow and working-capital characteristics.
- Entry barrier is the moat: Management calls FMCG "the most difficult area for any specialty chemical company to enter," noting that big brands took three years of effort starting before COVID to qualify Fineotex products.
- The large order ramp: A major FMCG order began with small consignments in November/December; less than ~₹10 crores executed in Q3 because FMCG companies need time to readjust supply chains and inventories. The bulk was postponed to January, and Q4 volumes are expected to out-beat earlier quarters.
- Customer pipeline widening: Very high interest from big international multinational giants; a lot of product evaluation is ongoing for different applications, and the team expects to further diversify the FMCG customer base.
- Raw-material linkage benefit: There is 90–95% correlation in raw materials between FMCG and textile product lines, so procurement benefits for FMCG raw materials also flow to textiles, improving overall EBITDA.
Tibrewala: "the most difficult part for any specialty chemical company would be to enter the FMCG. FMCG is one area which is really-really a challenge and it's one of the best sweet areas to be because you are sure of sustainable businesses as the demands in FMCGs doesn't fluctuate as much as it fluctuates in the textile businesses."
Margin Structure: Resilience, Mix Effects and the New-Plant Overhead
- Q3 margin achievement: EBITDA margin reached 26.1% and PAT margin 20.6% in Q3, supported by financial discipline and operational efficiency, despite commissioning a new plant that brings pre-operative and revenue expenses before any production.
- The automation lever: Automation, remarkable machinery infrastructure and larger reactor sizes have reduced manpower and labor overheads; overall overhead cost per kilo has gone down considerably.
- Raw-material tailwind: When basic chemical raw-material prices decline, EBITDA margins expand; this also motivates more marketing and promotional spending.
- Segment margin similarity: Textiles carry higher gross margins but also higher technical-service expenses (plant audits, product certifications, German audits); cleaning & hygiene has lower overheads for technical services. Blended EBITDA margins across segments are almost similar, with fluctuation not more than 100 bps either way.
- New-order margin parity: EBITDA margins on the ₹150-crore FMCG order (₹49–50/kg realization) are similar to the first product (₹65–70/kg) because overheads in this business are much lower than textile specialty: no exhibitions, fewer technical doctors for servicing.
- Management's margin floor: The nine-month average of 21.6% is viewed as the minimum level; margins are expected to stay between the current quarter's achieved level and that average for at least the next few quarters.
Tibrewala: "our company is a very high-end specialty chemical producer. We are not those kinds of companies where you will find our EBITDA sometimes 5%, sometimes 35%, this will never happen with Fineotex. And this is not our business model. When we sell our products, we sell as a solution."
Textile: Cyclical Softness, Not Structural Damage
- What happened: Demand per product per customer reduced or orders got postponed, but no products or customers were lost; from 14–15 January onwards, things are getting much-much better.
- The cotton-price mechanism: When cotton prices go up, big global buyers stop ordering because enough fabric/garments are in the pipeline for one season; when cotton and chemical raw-material prices correct, buyers keep low inventory levels expecting further price drops. This is the reverse of last year, when prices were rising due to the Chinese factor, freight costs and container shortages.
- The viewing framework: Management explicitly asks investors not to view textiles quarter by quarter but on a two-year average, to understand where it was and where it is now.
- Recovery signal: Demands are coming back, experienced in the last 15 days (from mid-January 2023); while completing Q4, it should be much-much better than the last six months.
Tibrewala: "textile will no longer be an industry, which one can view quarter-by-quarter. This is something to be viewed on an average of two years and understand where it was, where it is now."
Capacity, Utilization and the Next Capex Trigger
- Expansion completed: New 21,000 MTPA production capacity commissioned on 14 November 2022, taking total capacity from 84,000 to 104,000 MTPA. A third building has been erected at Ambernath with quite enough space for further expansion.
- Utilization trajectory: Quarter-by-quarter utilization has gone through remarkable extent, necessitating step-by-step expansion; management is quite hopeful that by Q4 FY23, the last expansion of 21,000 tons will be utilized in a good way.
- Q4 volume target: Current-quarter volumes expected to be very high, targeting 18,000–20,000 tons per quarter.
- FY24 utilization math: Annualizing the Q4 run-rate of ~20,000 tons gives ~80,000 tons (~80% utilization); management believes optimum utilization with new plant/machinery will reach ~85%. At 80,000–85,000 tons on ~1 lakh capacity, further capacity addition will be needed.
- Peak revenue potential: At 85% utilization and average realization of ₹80–90/kg, ₹700–800 crores revenue is comfortably seen with current capacities; higher-value-added textile products will help reach there.
- Next capex timeline: By next month, management will be able to plan the next round of capex; the timeline will not take too much time because most infrastructure (administrative, environmental permissions, planning, structuring, machinery foundations, building foundations) is already well laid-off.
Balance Sheet & Capital Allocation
- Working capital transformation: Working capital days reduced from 140 to 90–94 levels, driven by the product-mix shift toward FMCG (better payment terms and supply cycles) and more prudent cash-payment policies in textiles, including cash-discount schemes for dealers.
- Cash conversion: ~87% of EBITDA converted to operating cash flow in 9M FY23.
- Credit rating upgrade: Long-term debt upgraded to CRISIL A/Stable (from A-); short-term debt upgraded to CRISIL A1 (from CRISIL A2+); also received a new rating from ICRA.
- Inorganic appetite: Open to acquisitions with strong synergy in chemistry or market segments (cleaning, hygiene, textiles, oil & gas); conservative on valuation; no immediate deal shaped up; internal accruals will fund such activity.
- Strategic focus: Will not diversify into unrelated areas; focus remains on cleaning & hygiene and textiles, aiming to move into branded/FMCG sector and keep adding specialty products via R&D.
Tibrewala: "We don't want to be a general physician, we want to be a cardiologist. And we are one of that and that's the way we are working towards our customers, giving them more value-added products..."
Growth Algorithm: 25–30% With Organic Levers
- The headline ambition: Management is confident of 25–30% growth continuing for the next two to three years; the 12-year listed CAGR is 24%.
- What is changing now: Efforts started in 2019 are paying off; major benefits will be visible from this quarter onward for the next two years; textile is expected to come back very soon.
- R&D and technical build-out: A new strong technical team with doctors, including talent from ICT and technology universities serving as panel doctors, has been assembled; several new R&D achievements and new products are under process.
- Index and recognition milestones: Inducted as an A Group company, included in Nifty Microcap Index and Morgan Stanley CI Small Cap Index, certified as a Great Place to Work, and received US EPA approval for its best-selling antimicrobial treatment HealthGuard AMIC.
Tibrewala: "we have no way looking back below what you mentioned about the growth rate. But this is something which is definite, we will be achieving as such, but we would like to do something what we have done in the last two years, we would like to go to a different level of growth percentages organically."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| FMCG order volume ramp | Bulk of large FMCG order ships; volumes out-beat earlier quarters | Q4 FY23 |
| Quarterly volume run-rate | 18,000–20,000 tons per quarter | Q4 FY23 |
| Capacity utilization | Last 21,000-ton expansion utilized in a good way | Q4 FY23 |
| Next capex plan | Management able to plan next round of capex | February 2023 |
| EBITDA margin floor | Margins stay between current quarter's level and 21.6% nine-month average | Next few quarters |
| Organic growth rate | 25–30% growth continuing | Next 2–3 years |
| FMCG turnover share | Cleaning & hygiene contributing 40–50% of overall turnover | Going forward |
| Peak revenue from current capacity | ₹700–800 crores at 85% utilization and ₹80–90/kg realization | When utilization reaches 85% |
| Further capacity addition | Additional capacity needed once 80,000–85,000 tons run-rate achieved on ~1 lakh capacity | When utilization reaches ~85% |
Key Metrics
| Metric | Q3 FY23 |
|---|---|
| Operational revenue | ₹109.2 crore, up from ₹105.1 crore |
| 9M FY23 operational revenue | ₹379 crores, +54% YoY |
| EBITDA | ₹28.6 crore, +14% from ₹25.1 crore |
| EBITDA margin | 26.1%, vs 21.1% nine-month average |
| PAT | ₹22.5 crore, +17.8% from ₹19.1 crore |
| PAT margin | 20.6% |
| 9M FY23 PAT | ₹63.6 crores, +59.3% YoY, PAT margin of 16.8% |
| Volume growth | 100.12% YoY |
| Cleaning and hygiene share of sales | 40% of Q3 turnover |
| 9M FY23 operating cash flow | ~87% of EBITDA |
| Annualized ROCE | 29.1% |
| Annualized RoE | 35% |
| Working capital days | 94 days, down from 140 days |
| Total production capacity | 1,04,000 tons annually, up from 83,000 tons |
| 9M FY23 total volume | ~38,000 tons |